{"schema_version":"secwatch.filing_event.v1","accession":"0001641489-25-000030","form_type":"8-K","ticker":"VTVT","cik":"0001641489","company_name":"vTv Therapeutics Inc.","filed_at":"2025-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.171172+00:00","generated_at":"2026-05-21T03:21:57.143988+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"vTv Therapeutics posts May 2025 investor presentation on website","bullets":["Presentation posted on May 16, 2025 for use in investor and analyst meetings.","Slide deck highlights the company's focus on type 1 diabetes.","No new financial or clinical data were disclosed in the presentation."],"urls":{"canonical":"https://secwatch.observer/filing/0001641489-25-000030","json":"https://secwatch.observer/filing/0001641489-25-000030.json","markdown":"https://secwatch.observer/filing/0001641489-25-000030.md","text":"https://secwatch.observer/filing/0001641489-25-000030.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641489/000164148925000030/0001641489-25-000030-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641489/000164148925000030/vtvt-20250516.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T03:21:57.143988+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}